Items where Author is "Hissar, S"
Article
Pavan Kumar, N and Nancy, P and Hissar, S and Sivakumar, S and Viswanathan, V and Bethunaickan, R and Kornfeld, H and Babu, S. (2026) Complement profiling for treatment outcomes in pulmonary TB. Complement profiling for treatment outcomes in pulmonary TB, 17 (167994). pp. 1-10.
Dasan, B and Munisankar, S and Kumar, NP and Moideen, K. and Pandiarajan, AN and Nott, S and Viswanathan, V and Shanmugam, S and Hissar, S and Thiruvengadam, K. and Kornfeld, H and Babu, S. (2025) Impact of cytomegalovirus exposure on disease severity, bacterial burden, immune responses and treatment outcomes in tuberculosis. Impact of cytomegalovirus exposure on disease severity, bacterial burden, immune responses and treatment outcomes in tuberculosis, 16 (161270).
Pavan Kumar, N and Hissar, S and Nancy, A and Thiruvengadam, K. and Banurekha, VV and Balaji, S and Elilarasi, S and Gomathi, N S and Ganesh, J and Aravind, MA and Baskaran, D and Swaminathan, S and Babu, S. (2025) Plasma Matrix Metalloproteinases Signature as Biomarkers for Pediatric Tuberculosis Diagnosis: A Prospective Case–Control Study. Plasma Matrix Metalloproteinases Signature as Biomarkers for Pediatric Tuberculosis Diagnosis: A Prospective Case–Control Study, 13(6) (171).
Pavan Kumar, N and Rajamariyam, M and Nancy, A and Kumar, BS and Janakiram, M and Ahamed, SF and Kumar, V and Vijila, S and Sekar, S and Kuralmozhi, R and Baskaran, D and Hissar, S and Babu, S. (2025) Acute-phase proteins as biomarkers of inflammation in HIV patients with latent tuberculosis: a prospective study. Acute-phase proteins as biomarkers of inflammation in HIV patients with latent tuberculosis: a prospective study, 16 (155177).
Nancy Pandiarajan, A and Kumar, N P and Moideen, K. and Thiruvengadam, K. and Hissar, S and Sivakumar, S and Bethunaickan, R and Viswanathan, V and Kornfeld, Hardy and Babu, S. (2025) Association of Altered Baseline Hematological Parameters with Adverse Tuberculosis Treatment Outcomes. Association of Altered Baseline Hematological Parameters with Adverse Tuberculosis Treatment Outcomes, 14(2) (146). pp. 1-14.
Rajamanickam, A and Kothandaraman, SP and Kumar, NP and Viswanathan, V and Shanmugam, S and Hissar, S and Nott, S and Kornfeld, H and Babu, S. (2024) Cytokine and chemokine profiles in pulmonary tuberculosis with pre-diabetes. Cytokine and chemokine profiles in pulmonary tuberculosis with pre-diabetes, 29(15) (144716).
Velayutham, B. and Hissar, S and Thiruvengadam, K. and Narayan Sivaramakrishnan, G and Subramanyam, B and Navaneethapandian, P and Reddy, D and Nair, D. and Kannabiran, B and Balaji, S and Luke Elizabeth, H and Dhanaraj, B. and Natrajan, M. and Swaminathan, S (2024) Xpert MTB/RIF assay in the diagnosis of pulmonary tuberculosis in children in tertiary care setting in South India. Xpert MTB/RIF assay in the diagnosis of pulmonary tuberculosis in children in tertiary care setting in South India, 70(5) (fmae02).
Rajendran, P and Thomas, SV and Balaji, S and Selladurai, E. and Jayachandran, G and Malayappan, A and Bhaskar, A and Palanisamy, S and Ramamoorthy, T and Hasini, S and Hissar, S and Chandrasekaran, Padmapriyadarsini (2024) Paediatric pulmonary disease—are we diagnosing it right? Paediatric pulmonary disease—are we diagnosing it right?, 12 (137068).


Up a level